BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30414280)

  • 1. The analysis of human leukocyte antigen-G level in patients with endometrial cancer by Western blot technique.
    Walentowicz-Sadlecka M; Dziobek K; Grabiec M; Sadlecki P; Walentowicz P; Mak P; Szymankiewicz M; Kwinta P; Dutsch-Wicherek M
    Am J Reprod Immunol; 2019 Jan; 81(1):e13070. PubMed ID: 30414280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-G (HLA-G) expression plays an important role in the diagnosis and grading of endometrial cancer.
    Bai Y; Liu W; Xie Y; Liang J; Wang F; Li C
    J Obstet Gynaecol; 2022 May; 42(4):641-647. PubMed ID: 34382498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
    Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.
    Xu YF; Lu Y; Cheng H; Jiang J; Xu J; Long J; Liu L; Ni Q; Liu C; Yu XJ
    Curr Mol Med; 2015; 15(4):360-7. PubMed ID: 25829020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer.
    Ben Yahia H; Boujelbene N; Babay W; Ben Safta I; Dhouioui S; Zemni I; Ali Ayadi M; Charfi L; Ouzari HI; Rebmann V; Rizzo R; Mrad K; Driss M; Zidi I
    Hum Immunol; 2020 Jun; 81(6):305-313. PubMed ID: 32273131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
    Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
    Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
    Versluis MAC; Marchal S; Plat A; de Bock GH; van Hall T; de Bruyn M; Hollema H; Nijman HW
    Eur J Cancer; 2017 Nov; 86():285-295. PubMed ID: 29059634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasmatic soluble HLA-G levels in endometrial cancer.
    Ben Yahia H; Babay W; Bortolotti D; Boujelbene N; Laaribi AB; Zidi N; Kehila M; Chelbi H; Boudabous A; Mrad K; Mezlini A; Di Luca D; Ouzari HI; Rizzo R; Zidi I
    Mol Immunol; 2018 Jul; 99():82-86. PubMed ID: 29730546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma.
    Barrier BF; Kendall BS; Sharpe-Timms KL; Kost ER
    Gynecol Oncol; 2006 Oct; 103(1):25-30. PubMed ID: 16530254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
    König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
    Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
    Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
    Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic.
    Swets M; Wouters A; Krijgsman D; van Vlierberghe RLP; Boot A; van Eendenburg JD; van Wezel T; Gelderblom H; van de Velde CJH; van den Elsen PJ; Kuppen PJK
    Clin Immunol; 2018 Sep; 194():80-86. PubMed ID: 30006120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.
    Babay W; Ben Yahia H; Boujelbene N; Zidi N; Laaribi AB; Kacem D; Ben Ghorbel R; Boudabous A; Ouzari HI; Rizzo R; Rebmann V; Mrad K; Zidi I
    Hum Immunol; 2018 Jun; 79(6):463-470. PubMed ID: 29499226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer.
    Ye SR; Yang H; Li K; Dong DD; Lin XM; Yie SM
    Mod Pathol; 2007 Mar; 20(3):375-83. PubMed ID: 17277760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the expression of human leukocyte antigen G and preeclampsia].
    Zhao SC; Li ZB; He TQ; Yu CZ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):758-62. PubMed ID: 22321350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
    Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression.
    Li XJ; Zhang X; Lin A; Ruan YY; Yan WH
    Hum Immunol; 2012 Sep; 73(9):946-9. PubMed ID: 22820627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
    Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
    Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
    Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
    J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.